Eli Lilly (LLY) is a publicly traded Healthcare sector company. As of July 22, 2026, LLY trades at $1,158.08 with a market cap of $1.02T and a P/E ratio of 50.70. LLY moved -1.27% today. Year to date, LLY is +9.37%; over the trailing twelve months it is +54.22%. Its 52-week range spans $623.78 to $1,249.45. Analyst consensus is strong buy with an average price target of $1,350.89. Rallies surfaces LLY's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Eli Lilly (LLY) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. LLY moved -1.27% today. Analyst consensus is strong buy.
| Metric | Value |
|---|---|
| Price | $1,158.08 |
| Market Cap | $1.02T |
| P/E Ratio | 50.70 |
| EPS | $23.00 |
| Dividend Yield | 1.73% |
| 52-Week High | $1,249.45 |
| 52-Week Low | $623.78 |
| Volume | 833.34K |
| Avg Volume | 0 |
| Revenue (TTM) | $65.18B |
| Net Income | $20.64B |
| Gross Margin | 83.04% |
21 analysts cover LLY: 0 strong buy, 19 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $1,350.89.